These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 37296313)

  • 1. Applying genomics in regulatory toxicology: a report of the ECETOC workshop on omics threshold on non-adversity.
    Gant TW; Auerbach SS; Von Bergen M; Bouhifd M; Botham PA; Caiment F; Currie RA; Harrill J; Johnson K; Li D; Rouquie D; van Ravenzwaay B; Sistare F; Tralau T; Viant MR; van de Laan JW; Yauk C
    Arch Toxicol; 2023 Aug; 97(8):2291-2302. PubMed ID: 37296313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress towards an OECD reporting framework for transcriptomics and metabolomics in regulatory toxicology.
    Harrill JA; Viant MR; Yauk CL; Sachana M; Gant TW; Auerbach SS; Beger RD; Bouhifd M; O'Brien J; Burgoon L; Caiment F; Carpi D; Chen T; Chorley BN; Colbourne J; Corvi R; Debrauwer L; O'Donovan C; Ebbels TMD; Ekman DR; Faulhammer F; Gribaldo L; Hilton GM; Jones SP; Kende A; Lawson TN; Leite SB; Leonards PEG; Luijten M; Martin A; Moussa L; Rudaz S; Schmitz O; Sobanski T; Strauss V; Vaccari M; Vijay V; Weber RJM; Williams AJ; Williams A; Thomas RS; Whelan M
    Regul Toxicol Pharmacol; 2021 Oct; 125():105020. PubMed ID: 34333066
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applying 'omics technologies in chemicals risk assessment: Report of an ECETOC workshop.
    Buesen R; Chorley BN; da Silva Lima B; Daston G; Deferme L; Ebbels T; Gant TW; Goetz A; Greally J; Gribaldo L; Hackermüller J; Hubesch B; Jennen D; Johnson K; Kanno J; Kauffmann HM; Laffont M; McMullen P; Meehan R; Pemberton M; Perdichizzi S; Piersma AH; Sauer UG; Schmidt K; Seitz H; Sumida K; Tollefsen KE; Tong W; Tralau T; van Ravenzwaay B; Weber RJM; Worth A; Yauk C; Poole A
    Regul Toxicol Pharmacol; 2017 Dec; 91 Suppl 1(Suppl 1):S3-S13. PubMed ID: 28958911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Towards the development of an omics data analysis framework.
    Verheijen M; Tong W; Shi L; Gant TW; Seligman B; Caiment F
    Regul Toxicol Pharmacol; 2020 Apr; 112():104621. PubMed ID: 32087354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Omics in the Application of Adverse Outcome Pathways for Chemical Risk Assessment.
    Brockmeier EK; Hodges G; Hutchinson TH; Butler E; Hecker M; Tollefsen KE; Garcia-Reyero N; Kille P; Becker D; Chipman K; Colbourne J; Collette TW; Cossins A; Cronin M; Graystock P; Gutsell S; Knapen D; Katsiadaki I; Lange A; Marshall S; Owen SF; Perkins EJ; Plaistow S; Schroeder A; Taylor D; Viant M; Ankley G; Falciani F
    Toxicol Sci; 2017 Aug; 158(2):252-262. PubMed ID: 28525648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next generation testing strategy for assessment of genomic damage: A conceptual framework and considerations.
    Dearfield KL; Gollapudi BB; Bemis JC; Benz RD; Douglas GR; Elespuru RK; Johnson GE; Kirkland DJ; LeBaron MJ; Li AP; Marchetti F; Pottenger LH; Rorije E; Tanir JY; Thybaud V; van Benthem J; Yauk CL; Zeiger E; Luijten M
    Environ Mol Mutagen; 2017 Jun; 58(5):264-283. PubMed ID: 27650663
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse outcome pathway: a path toward better data consolidation and global co-ordination of radiation research.
    Chauhan V; Beaton D; Hamada N; Wilkins R; Burtt J; Leblanc J; Cool D; Garnier-Laplace J; Laurier D; Le Y; Yamada Y; Tollefsen KE
    Int J Radiat Biol; 2022; 98(12):1694-1703. PubMed ID: 34919011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk assessment of endocrine active chemicals: identifying chemicals of regulatory concern.
    Bars R; Fegert I; Gross M; Lewis D; Weltje L; Weyers A; Wheeler JR; Galay-Burgos M
    Regul Toxicol Pharmacol; 2012 Oct; 64(1):143-54. PubMed ID: 22735369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A curated gene and biological system annotation of adverse outcome pathways related to human health.
    Saarimäki LA; Fratello M; Pavel A; Korpilähde S; Leppänen J; Serra A; Greco D
    Sci Data; 2023 Jun; 10(1):409. PubMed ID: 37355733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluating biological variation in non-transgenic crops: executive summary from the ILSI Health and Environmental Sciences Institute workshop, November 16-17, 2009, Paris, France.
    Doerrer N; Ladics G; McClain S; Herouet-Guicheney C; Poulsen LK; Privalle L; Stagg N
    Regul Toxicol Pharmacol; 2010 Dec; 58(3 Suppl):S2-7. PubMed ID: 20615445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicogenomics Data for Chemical Safety Assessment and Development of New Approach Methodologies: An Adverse Outcome Pathway-Based Approach.
    Saarimäki LA; Morikka J; Pavel A; Korpilähde S; Del Giudice G; Federico A; Fratello M; Serra A; Greco D
    Adv Sci (Weinh); 2023 Jan; 10(2):e2203984. PubMed ID: 36479815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of the application of 'omics technologies in chemicals risk assessment: Background and outlook.
    Sauer UG; Deferme L; Gribaldo L; Hackermüller J; Tralau T; van Ravenzwaay B; Yauk C; Poole A; Tong W; Gant TW
    Regul Toxicol Pharmacol; 2017 Dec; 91 Suppl 1():S14-S26. PubMed ID: 28927750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of toxicogenomics and traditional approaches to inform mode of action and points of departure in human health risk assessment of benzo[a]pyrene in drinking water.
    Moffat I; Chepelev N; Labib S; Bourdon-Lacombe J; Kuo B; Buick JK; Lemieux F; Williams A; Halappanavar S; Malik A; Luijten M; Aubrecht J; Hyduke DR; Fornace AJ; Swartz CD; Recio L; Yauk CL
    Crit Rev Toxicol; 2015 Jan; 45(1):1-43. PubMed ID: 25605026
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drivers of and Obstacles to the Adoption of Toxicogenomics for Chemical Risk Assessment: Insights from Social Science Perspectives.
    Pain G; Hickey G; Mondou M; Crump D; Hecker M; Basu N; Maguire S
    Environ Health Perspect; 2020 Oct; 128(10):105002. PubMed ID: 33112659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
    Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
    Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advancing the use of noncoding RNA in regulatory toxicology: Report of an ECETOC workshop.
    Aigner A; Buesen R; Gant T; Gooderham N; Greim H; Hackermüller J; Hubesch B; Laffont M; Marczylo E; Meister G; Petrick JS; Rasoulpour RJ; Sauer UG; Schmidt K; Seitz H; Slack F; Sukata T; van der Vies SM; Verhaert J; Witwer KW; Poole A
    Regul Toxicol Pharmacol; 2016 Dec; 82():127-139. PubMed ID: 27663666
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ECETOC Florence workshop on risk assessment of endocrine substances, including the potency concept.
    Fegert I
    Toxicol Lett; 2013 Dec; 223(3):310-4. PubMed ID: 23558296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A high-level overview of the OECD AOP Development Programme.
    Chauhan V; Hamada N; Wilkins R; Garnier-Laplace J; Laurier D; Beaton D; Tollefsen KE
    Int J Radiat Biol; 2022; 98(12):1704-1713. PubMed ID: 35938955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of NAMs and omics data in risk assessment.
    ; Miccoli A; Marx-Stoelting P; Braeuning A
    EFSA J; 2022 Dec; 20(Suppl 2):e200908. PubMed ID: 36531284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.